Huntington Bancshars Inc. Pfd Ser A
HBANP
HBANP was delisted on the 22nd of February, 2018.
0 hedge funds and large institutions have $0 invested in Huntington Bancshars Inc. Pfd Ser A in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 49 closing their positions.
100% less funds holding
Funds holding: 49 → 0 (-49)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $339M → $0 (-$339M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 49
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$84.7M |
| 2 |
CAM
Camden Asset Management
Los Angeles,
California
|
-$80.1M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$28.1M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$27.2M |
| 5 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
-$22.5M |
HBANP Hedge Fund Activity: Q1 2018 in Review
0 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Huntington Bancshars Inc. Pfd Ser A (HBANP) for Q1 2018, worth a combined $0 — down 100% from $339M a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of HBANP and 0 opened new positions — a net loss of 49 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Manulife (Manufacturers Life Insurance), exiting entirely with an estimated $84.7M sold.
- 0 institutional investors held Huntington Bancshars Inc. Pfd Ser A (HBANP) as of Q1 2018, down from 49 in Q4 2017.
- Funds reported $0 of Huntington Bancshars Inc. Pfd Ser A stock for Q1 2018, down 100% quarter-over-quarter.
- 0 funds opened new Huntington Bancshars Inc. Pfd Ser A positions in Q1 2018 and 49 closed out, a net change of -49 holders.
- The largest Huntington Bancshars Inc. Pfd Ser A seller in Q1 2018 was Manulife (Manufacturers Life Insurance), an estimated $84.7M sold.
Based on aggregated 13F filings for Q1 2018.